Yixin Bao
Overview
Yixin is an associate at Crowell & Moring’s Chicago office, focusing on intellectual property, including patents, trademarks, and copyrights. She works with clients globally, gaining insight into their distinct business needs and concerns.
Yixin has supported partners and counsels in complex patent litigation, helping to develop strategies to protect and enforce clients' patent rights across various industries. She has also managed patent applications, ensuring clients' innovations are protected through drafting responses to office actions before the U.S. Patent and Trademark Office. Yixin works with clients both in the U.S. and internationally, addressing the needs of a global clientele. Additionally, she has expanded her knowledge to include trademark prosecution, searching, portfolio management, and litigation.
Career & Education
- Student Associate, University of Washington Entrepreneurial Law Clinic, 2023–2024
- Editorial Staff, Washington Journal of Law, Technology, & Arts, 2023–2024
- Judicial Extern to the Honorable Justice Mary Yu at the Washington Supreme Court, 2023
- University of Illinois at Urbana Champaign, B.S., Mathematics, Statistics, and Political Science, 2019
- University of Washington, J.D., 2024
- Illinois
- Mandarin
Yixin's Insights
Client Alert | 4 min read | 05.12.26
On April 30, 2026, USPTO Director John A. Squires issued an updated memorandum superseding the December 4, 2025, guidance on Best Practices for Submission of Rule 132 Subject Matter Eligibility Declarations (SMEDs). The USPTO has also created a new position — Deputy Commissioner for Patents focusing on AI Policy, Practice, and Operations — and has welcomed longtime practitioner and private-sector AI expert Barry Schindler to this role. This alert summarizes the key updates and actionable guidance for patent applicants and practitioners.
Firm News | 1 min read | 07.09.25
Tahirih Justice Center Honors Crowell & Moring with Pro Bono Team of the Year Recognition
Client Alert | 4 min read | 03.24.25
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars?
Insights
Yixin's Insights
Client Alert | 4 min read | 05.12.26
On April 30, 2026, USPTO Director John A. Squires issued an updated memorandum superseding the December 4, 2025, guidance on Best Practices for Submission of Rule 132 Subject Matter Eligibility Declarations (SMEDs). The USPTO has also created a new position — Deputy Commissioner for Patents focusing on AI Policy, Practice, and Operations — and has welcomed longtime practitioner and private-sector AI expert Barry Schindler to this role. This alert summarizes the key updates and actionable guidance for patent applicants and practitioners.
Firm News | 1 min read | 07.09.25
Tahirih Justice Center Honors Crowell & Moring with Pro Bono Team of the Year Recognition
Client Alert | 4 min read | 03.24.25
USPTO Finds Claims of Two of Moderna’s mRNA Patents Unpatentable: What’s Next in the Vaccine Wars?
